Role of VEGFR‐1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib

The vascular endothelial growth factor receptor‐1 (VEGFR‐1) is a tyrosine kinase receptor frequently expressed in melanoma. Its activation by VEGF‐A or placental growth factor (PlGF) promotes tumour cell survival, migration and invasiveness. Moreover, VEGFR‐1 stimulation contributes to pathological...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Cell Mol Med
Hoofdauteurs: Atzori, Maria Grazia, Ceci, Claudia, Ruffini, Federica, Trapani, Mauro, Barbaccia, Maria Luisa, Tentori, Lucio, D'Atri, Stefania, Lacal, Pedro Miguel, Graziani, Grazia
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2019
Onderwerpen:
Original Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6933379/
https://ncbi.nlm.nih.gov/pubmed/31758648
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14755
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items